Reviewed,
UniProtKB/Swiss-Prot Q9BUM1 (G6PC3_HUMAN)
Last modified
July 7, 2009.
Version 61.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Glucose-6-phosphatase 3 Short name=G-6-Pase 3 Short name=G6Pase 3 EC=3.1.3.9 Alternative name(s): Glucose-6-phosphatase beta Short name=G6Pase-beta Ubiquitous glucose-6-phosphatase catalytic subunit-related protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 346 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Hydrolyzes glucose-6-phosphate to glucose in the endoplasmic reticulum. May form with the glucose-6-phosphate transporter (SLC37A4/G6PT) a ubiquitously expressed complex responsible for glucose production through glycogenolysis and gluconeogenesis. Probably required for normal neutrophil function. Ref.3 Ref.4 Ref.5 |
| Catalytic activity | D-glucose 6-phosphate + H2O = D-glucose + phosphate. Ref.4 |
| Enzyme regulation | Inhibited by vanadate. Ref.5 |
| Pathway | |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein. Ref.5 |
| Tissue specificity | Ubiquitously expressed. Highly expressed in skeletal muscle, at intermediate levels in heart, brain, placenta, kidney, colon, thymus, spleen and pancreas. Also detected in testis, prostate, ovary, liver, lung, small intestine and peripheral blood lymphocytes. Ref.3 Ref.4 Ref.7 |
| Involvement in disease | Defects in G6PC3 are the cause of autosomal recessive severe congenital neutropenia type 4 (SCN4) [MIM:612541]. Autosomal recessive SCN constitutes a primary immunodeficiency syndrome associated with increased apoptosis in myeloid cells. Individuals show a paucity of mature neutrophils in peripheral blood and bone marrow and develop life-threatening bacterial infections. SCN4 is a severe congenital neutropenia syndrome associated with cardiac and urogenital malformations. |
| Sequence similarities | Belongs to the glucose-6-phosphatase family. |
| Caution | According to Ref.3 it has no hydrolytic activity. |
| Biophysicochemical properties | Kinetic parameters: 8 times less active compared to G6PC under the same experimental conditions. KM=1.0 mM for glucose-6-phosphate (at pH 5.5.) KM=2.0 mM for glucose-6-phosphate (at pH 6.5.) |
Ontologies
| Keywords | |
|---|---|
| Biological process | Gluconeogenesis |
| Cellular component | Endoplasmic reticulum Membrane |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation |
| Domain | Transmembrane |
| Molecular function | Hydrolase |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | gluconeogenesis Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | endoplasmic reticulum membrane Inferred from electronic annotation. Source: UniProtKB-SubCell integral to membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | glucose-6-phosphatase activity Inferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 346 | 346 | Glucose-6-phosphatase 3 | PRO_0000334512 | |||||
Regions | |||||||||
| Topological domain | 1 – 24 | 24 | Lumenal Potential | ||||||
| Transmembrane | 25 – 45 | 21 | Potential | ||||||
| Topological domain | 46 – 54 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 55 – 75 | 21 | Potential | ||||||
| Topological domain | 76 – 114 | 39 | Lumenal Potential | ||||||
| Transmembrane | 115 – 135 | 21 | Potential | ||||||
| Topological domain | 136 – 146 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 147 – 164 | 18 | Potential | ||||||
| Topological domain | 165 – 169 | 5 | Lumenal Potential | ||||||
| Transmembrane | 170 – 186 | 17 | Potential | ||||||
| Topological domain | 187 – 197 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 198 – 218 | 21 | Potential | ||||||
| Topological domain | 219 – 254 | 36 | Lumenal Potential | ||||||
| Transmembrane | 255 – 273 | 19 | Potential | ||||||
| Topological domain | 274 – 283 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 284 – 304 | 21 | Potential | ||||||
| Topological domain | 305 – 307 | 3 | Lumenal Potential | ||||||
| Transmembrane | 308 – 328 | 21 | Potential | ||||||
| Topological domain | 329 – 346 | 18 | Cytoplasmic Potential | ||||||
Sites | |||||||||
| Active site | 114 | 1 | Proton donor Potential | ||||||
| Active site | 167 | 1 | Nucleophile Ref.6 | ||||||
| Binding site | 79 | 1 | Substrate Potential | ||||||
| Binding site | 161 | 1 | Substrate Potential | ||||||
Natural variations | |||||||||
| Natural variant | 185 | 1 | L → P in SCN4. | VAR_055156 | |||||
| Natural variant | 216 | 1 | T → I: dbSNP rs34406052. | VAR_043378 | |||||
| Natural variant | 253 | 1 | R → H in SCN4; the mutant protein has no phosphatase activity in vitro; electron microscopic studies show enlarged rough endoplasmic reticulum consistent with increased stress. | VAR_055157 | |||||
| Natural variant | 262 | 1 | G → R in SCN4. | VAR_055158 | |||||
Experimental info | |||||||||
| Mutagenesis | 79 | 1 | R → A: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 114 | 1 | H → A: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 167 | 1 | H → A: Loss of catalytic activity. Ref.5 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Eye and Skin. |
| [3] | "Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein." Martin C.C., Oeser J.K., Svitek C.A., Hunter S.I., Hutton J.C., O'Brien R.M. J. Mol. Endocrinol. 29:205-222(2002) [PubMed: 12370122] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY. |
| [4] | "Identification and characterisation of a new human glucose-6-phosphatase isoform." Guionie O., Clottes E., Stafford K., Burchell A. FEBS Lett. 551:159-164(2003) [PubMed: 12965222] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY. |
| [5] | "A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia." Shieh J.-J., Pan C.-J., Mansfield B.C., Chou J.Y. J. Biol. Chem. 278:47098-47103(2003) [PubMed: 13129915] [Abstract] Cited for: FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, SUBCELLULAR LOCATION, MUTAGENESIS OF ARG-79; HIS-114 AND HIS-167. |
| [6] | "Histidine 167 is the phosphate acceptor in glucose-6-phosphatase-beta forming a phosphohistidine enzyme intermediate during catalysis." Ghosh A., Shieh J.-J., Pan C.-J., Chou J.Y. J. Biol. Chem. 279:12479-12483(2004) [PubMed: 14718531] [Abstract] Cited for: TOPOLOGY, ACTIVE SITE. |
| [7] | "Identification and characterization of a cDNA and the gene encoding the mouse ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein." Boustead J.N., Martin C.C., Oeser J.K., Svitek C.A., Hunter S.I., Hutton J.C., O'Brien R.M. J. Mol. Endocrinol. 32:33-53(2004) [PubMed: 14765991] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [8] | "A syndrome with congenital neutropenia and mutations in G6PC3." Boztug K., Appaswamy G., Ashikov A., Schaeffer A.A., Salzer U., Diestelhorst J., Germeshausen M., Brandes G., Lee-Gossler J., Noyan F., Gatzke A.-K., Minkov M., Greil J., Kratz C., Petropoulou T., Pellier I., Bellanne-Chantelot C., Rezaei N. Klein C.N. Engl. J. Med. 360:32-43(2009) [PubMed: 19118303] [Abstract] Cited for: VARIANTS SCN4 PRO-185; HIS-253 AND ARG-262, CHARACTERIZATION OF VARIANT SCN4 HIS-253. |
Cross-references
Sequence databases | |
|---|---|
| CH471178 Genomic DNA. Translation: EAW51638.1. BC002494 mRNA. Translation: AAH02494.2. BC021574 mRNA. Translation: AAH21574.1. | |
| IPI | IPI00031052. |
| RefSeq | NP_612396.1. |
| UniGene | Hs.294005 |
3D structure databases | |
| ModBase | Search... |
Proteomic databases | |
| PeptideAtlas | Q9BUM1. |
| PRIDE | Q9BUM1. |
Genome annotation databases | |
| Ensembl | ENSG00000141349. Homo sapiens. [Contig view] |
| GeneID | 92579. |
| KEGG | hsa:92579. |
| NMPDR | fig|9606.3.peg.13854. |
| UCSC | uc002iex.1. human. |
Organism-specific databases | |
| GeneCards | GC17P039503. |
| HGNC | HGNC:24861. G6PC3. |
| MIM | 611045. gene. 612541. phenotype. |
| Orphanet | 42738. Neutropenia, congenital. 486. Severe congenital neutropenia. |
| PharmGKB | PA134968446. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | Q9BUM1. |
| HOVERGEN | Q9BUM1. |
| OMA | Q9BUM1. GIAVLWI. |
Gene expression databases | |
| ArrayExpress | Q9BUM1. |
| Bgee | Q9BUM1. |
| CleanEx | HS_G6PC3. |
Family and domain databases | |
| InterPro | IPR016275. Glucose-6-phosphatase. IPR000326. P_Acid_Pase_2/haloperoxidase. [Graphical view] |
| Pfam | PF01569. PAP2. 1 hit. [Graphical view] |
| PIRSF | PIRSF000905. Glucose-6-phosphatase. 1 hit. |
| SMART | SM00014. acidPPc. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 77803. |
| SOURCE | Search... |
Entry information
| Entry name | G6PC3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9BUM1 Secondary accession number(s): Q8WU15 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with


